• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗高血压治疗中年龄相关效应分析的统计学陷阱。

Statistical pitfalls in the analysis of age-related effects in antihypertensive therapy.

作者信息

Murray G D, Lesaffre E

机构信息

University Department of Surgery, Western Infirmary, University of Glasgow, Scotland.

出版信息

J Cardiovasc Pharmacol. 1988;12 Suppl 8:S167-73.

PMID:2469898
Abstract

Much of the literature concerning age-related effects in antihypertensive therapy suffers from serious deficiencies in statistical design and analysis. The problems include those relating to the choice of a suitable control group, the measurement of response to treatment, response to baseline blood pressure, interpreting post hoc analyses, and the pooling of data from a number of related studies. These problems are discussed and we attempt to identify solutions that give a satisfactory balance between scientific validity and the real-life problems of conducting clinical trials. We conclude by outlining a protocol for future studies in this area.

摘要

许多关于抗高血压治疗中年龄相关效应的文献在统计设计和分析方面存在严重缺陷。这些问题包括与合适对照组的选择、治疗反应的测量、对基线血压的反应、事后分析的解释以及多项相关研究的数据汇总有关的问题。本文对这些问题进行了讨论,并试图找出在科学有效性与开展临床试验的实际问题之间取得令人满意平衡的解决方案。我们最后概述了该领域未来研究的方案。

相似文献

1
Statistical pitfalls in the analysis of age-related effects in antihypertensive therapy.抗高血压治疗中年龄相关效应分析的统计学陷阱。
J Cardiovasc Pharmacol. 1988;12 Suppl 8:S167-73.
2
Interpreting age-related aspects of antihypertensive treatment: statistical defects and their remedy.
J Hypertens Suppl. 1988 Nov;6(1):S121-6.
3
Comparative studies in hypertension: some fallacious claims of age-related drug efficacy.高血压的比较研究:一些关于年龄相关药物疗效的错误说法。
J Hypertens Suppl. 1990 Sep;8(4):S59-61.
4
Age dependency of blood pressure response to antihypertensive treatment: some methodological considerations and observations on five beta-adrenoceptor antagonists under different experimental conditions.血压对抗高血压治疗反应的年龄依赖性:关于五种β-肾上腺素能受体拮抗剂在不同实验条件下的一些方法学考量与观察
J Cardiovasc Pharmacol. 1988;12 Suppl 8:S93-9.
5
Hypertension in the elderly.老年人高血压
Basic Res Cardiol. 1998;93 Suppl 2:43-6.
6
The future of antihypertensive treatment.抗高血压治疗的未来。
Am J Ther. 2007 Mar-Apr;14(2):121-34. doi: 10.1097/01.pap.0000249915.12185.58.
7
The changing face of clinical trials.临床试验不断变化的面貌。
J Hypertens Suppl. 1988 Nov;6(1):S73-80.
8
[Review: arterial hypertension and advanced age].[综述:动脉高血压与高龄]
Nephrologie. 1989;10(1):5-10.
9
Potential mechanisms of stroke benefit favoring losartan in the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study.在氯沙坦干预降低高血压终点事件(LIFE)研究中,氯沙坦对中风有益的潜在机制。
Curr Med Res Opin. 2007 Feb;23(2):443-57. doi: 10.1185/030079906X167435.
10
[Hypertension and old age].[高血压与老年]
Schweiz Rundsch Med Prax. 1989 Nov 7;78(45):1247-54.

引用本文的文献

1
Serotonin-induced platelet aggregation predicts the antihypertensive response to serotonin receptor antagonists.血清素诱导的血小板聚集可预测对血清素受体拮抗剂的降压反应。
Eur J Clin Pharmacol. 1993;44(2):121-5. doi: 10.1007/BF00315468.
2
Prognostic significance of blood pressure in the very old. Implications for the treatment decision.高龄人群中血压的预后意义。对治疗决策的影响。
Drugs Aging. 1994 Sep;5(3):184-91. doi: 10.2165/00002512-199405030-00004.
3
Ageing, and treatment of hypertension.
Drugs. 1988;36 Suppl 1:1-6. doi: 10.2165/00003495-198800361-00003.
4
Ketanserin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in hypertension and peripheral vascular disease.酮色林。对其药效学和药代动力学特性以及在高血压和外周血管疾病中的治疗潜力的综述。
Drugs. 1990 Dec;40(6):903-49. doi: 10.2165/00003495-199040060-00010.
5
Newer beta blockers and the treatment of hypertension.新型β受体阻滞剂与高血压治疗
Cardiovasc Drugs Ther. 1991 Jun;5(3):577-87. doi: 10.1007/BF03029727.